Related Experiment Videos
Anaplastic carcinoma presenting with cervical lymphadenopathy.
J S Durham1, J Nash, G Rothery
1Department of Otorhinolaryngology, University of Liverpool, UK.
Clinical Otolaryngology and Allied Sciences
|December 1, 1990
Summary
Anaplastic carcinoma diagnosis in 50 patients confirmed by immunocytochemistry. Survival rates were similar regardless of primary tumor site identification, with age and tumor status impacting prognosis.
Area of Science:
- Oncology
- Pathology
Background:
- Anaplastic carcinoma is a rare and aggressive malignancy.
- Neck masses are a common presentation, necessitating accurate diagnosis.
Purpose of the Study:
- To describe the clinical characteristics, diagnostic methods, and survival outcomes of patients with anaplastic carcinoma.
- To identify prognostic factors influencing survival in anaplastic carcinoma.
Main Methods:
- Retrospective analysis of 50 patients diagnosed with anaplastic carcinoma.
- Immunocytochemistry used to confirm diagnosis and exclude other malignancies.
- Evaluation of primary tumor site, treatment, and survival data.
Main Results:
- Diagnosis confirmed by immunocytochemistry in 50 patients with neck masses.
- Primary tumor site identified in 31 patients (nasopharynx most common); unknown in 20.
- Two-year survival was approximately 30%, with no significant difference based on primary site identification.
- Age, performance status, and T status were significant prognostic factors.
Conclusions:
- Anaplastic carcinoma diagnosis requires careful exclusion of mimics using immunocytochemistry.
- Treatment and survival outcomes for anaplastic carcinoma are influenced by patient factors and tumor stage.
- Prognosis is generally poor, highlighting the need for further research into effective therapies.